Glen Harbor Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Glen Harbor Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,022	Closed	-$253K	–	1334
2018 Q1	$253K	Buy	13,022 +204	+2%	+$4K	0.01%	889
2017 Q4	$213K	Buy	12,818 +2,822	+28%	+$51.7K	﹤0.01%	951
2017 Q3	$203K	Buy	9,996 +782	+8%	+$14.9K	﹤0.01%	904
2017 Q2	$148K	Buy	9,214 +4,216	+84%	+$62.3K	﹤0.01%	957
2017 Q1	$63K	Buy	4,998 +850	+20%	+$10.3K	﹤0.01%	1081
2016 Q4	$55K	Buy	+4,148	New	+$70.9K	﹤0.01%	1073

Glen Harbor Capital Management's IPXL Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 13,022 shares — an estimated $253K sold.

Glen Harbor Capital Management first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $253K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Glen Harbor Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 13,022 Impax Laboratories, Inc. shares in Q2 2018, an estimated $253K.
Glen Harbor Capital Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
Glen Harbor Capital Management's Impax Laboratories, Inc. position peaked at $253K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.